Gene Drive Strategy to Combat Harmful Virus Spread
News Feb 19, 2016
With the outbreak of viruses like Zika, chikungunya, and dengue on the rise, public health officials are desperate to stop transmission.
Virginia Tech experts explore one way -- through the genetic engineering of mosquitoes to maleness -- in the Feb. 17 issue of the journal Trends in Parasitology.
In the paper, the researchers discuss how recent breakthroughs in CRISPR-Cas9 gene editing technology coupled with their discovery last year of a male sex determining gene Nix could be a winning combination for tipping the male-female mosquito ratio in the wild.
Male mosquitoes are harmless because they feed only on nectar; female mosquitoes need to feed on blood in order to produce eggs, and are solely responsible for disease transmission.
In the lab, Virginia Tech researchers have proven that adding Nix in female mosquito embryos could initiate male development.
"We are testing the hypothesis that insertion of key male determining genes such as Nix into the genome of female mosquitoes could produce fertile or sterile males or simply female lethality, all of which will result in less females," said Zhijian "Jake" Tu, a professor of biochemistry in the College of Agriculture and Life Sciences, co-author of the study and a Fralin Life Science Institute affiliate.
The next step, researchers said, is to understand how this technology might be useful in the wild.
"Combining Nix with CRISPR-Cas9 technology could really help us complete goals set and not reached by previous campaigns to eradicate Aedes aegypti mosquitoes, by driving maleness into wild populations," said Zach Adelman, an associate professor of entomology in the College of Agriculture and Life Sciences and co-author of the paper.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.